RORafał Oleszczuk

Rafał Oleszczuk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rafał Oleszczuk has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Placenta accreta spectrum (PAS) – a clinical case involving prophylactic internal iliac artery occlusion

    by Kinga Kalinowska, Kinga Kuranc, Ada Krasowska, Karolina Pawelec, Anna Semczuk-Sikora, Rafał Oleszczuk

    Placenta accreta spectrum (PAS) comprises a range of obstetric disorders characterized by abnormal placental invasion into the myometrium and surrounding tissues. The case is presented of placenta percreta in a 33-year-old gravida 5, para 3 patient with a history of three prior caesarean...

  • Open Access

    Neuropsychiatric dimensions of COVID-19 - literature review

    by Iga Kozińska, Rafał Oleszczuk, Anna Kozińska, Anna Oleszczuk

    SARS-CoV-2 infection leads to severe multiple organ failure. The immune system is stimulated by activating the inflammatory mechanism and by releasing inflammatory cytokines. COVID-19 is able to penetrate the central nervous system, inducing neuritis and neurodegeneration. In our study, we analyzed the latest available articles. We focused on the subject of COVID-19 infection and consequences of neuroinflammation. For this study, we searched the literature available in Pubmed and Google Scholar databases using keywords. There is evidence of a common background of COVID-19 complications and neurological diseases such as Parkinson's or Alzheimer's disease. This type of complication is more frequently observed in serious cases of COVID-19, with a more intense immune response, with higher levels of CRP, ferritin and D-dimers. Organic changes in conjunction with environmental stress caused by the experience of severe illness, fear of becoming ill and social limitations, lead to neuropsychiatric pathologies, including major depressive disorders and post-traumatic stress. The neuropsychiatric implications of COVID-19 represent a severe clinical problem that deserves special attention in the treatment of COVID-19 infection. There is a need to monitor the neuropsychiatric consequences of COVID-19, in order to completely understand the impact of SARS-CoV-2 infection. This knowledge is necessary to be able to confront the public health crisis created by the COVID-19 pandemic.

  • Open Access

    Nutritional treatment in chronic kidney disease - review article

    by Maciej Orczykowski, Rafał Oleszczuk, Jakub Mendocha, Agnieszka Grzebalska

    INTRODUCTION: Chronic Kidney Disease (CKD) is a condition affecting nearly 16% of the population. It is a disease that cannot be completely cured with modern medical capabilities. However, it is possible to halt the progression of the disease and postpone renal replacement therapy through pharmacotherapy. In order to monitor the progression of the disease, GFR should be determined. PURPOSE OF THE WORK: This article reviews the potential impact of typical Western diet and eating habits on the occurrence and progression of chronic kidney disease. Reducing the intake of animal protein, foods rich in sodium potassium and phosphorus, and increasing the intake of fruits, vegetables and fiber help prevent or delay end-stage renal disease. The literature on the role of a low-protein plant-based diet in patients with CKD was also reviewed. DESCRIPTION OF THE STATE OF KNOWLEDGE: In addition to pharmacological methods, whose main goal is to reduce proteinuria and control blood pressure, drug therapy can be supported by non-pharmacological methods. One of them is the use of a low-protein diet and adequate provision of macro- and micronutrients in the diet. SUMMARY: In order to support pharmacotherapy in the treatment of chronic kidney disease, the use of an appropriate diet plays an important role. According to the literature, the most important is restriction of protein supply, weight reduction in obese patients and supplementation of micronutrient deficiencies that occur.

  • Open Access

    Depression in regard to postcovid syndrome - literature review

    by Iga Kozińska, Rafał Oleszczuk, Sylwia Skwira, Aleksander Gras-Ozimek, Anna Kozińska, Anna Oleszczuk

    Coronavirus disease-2019 (COVID-19) is a global pandemic health problem that causes a wide spectrum of clinical manifestations. Recovered patients who survive COVID-19 may continue to report a wide variety of clinical manifestations such as depression, which is named post covid syndrome. In our article, we sought to determine the frequency and possible causes of depressive symptoms and clinically-significant depression in the post COVID syndrome. We conducted a review of postcovid manifestations by searching PubMed, Scopus, World health organization (WHO) databases. The symptoms of postcovid syndrome have been shown as a weakness, cognitive impairment, sleep disturbance, and depression, among others. Persistent mental disorders among people who suffer from long-term COVID-19 may be related to psychological factors, as well as from infection and the associated neurobiological trauma. According to available studies, a significant percentage of depression symptoms is observed among people with postcovid syndrome, especially in older age groups. Also symptoms of mental, neurological and physical illness as well as inflammatory brain injury in people with post-COVID syndrome are likely to increase suicidal ideation and behavior in this patient population.

  • Open Access

    What does the future look like - home hemodialysis

    by Weronika Buczek, Mikołaj Wiśniewski, Rafał Oleszczuk, Iga Kozińska, Anna Oleszczuk, Agnieszka M. Grzebalska

    Home hemodialysis (HHD) is a discovery from 1961 that is now experiencing a revival. It is a convenient and modern method of renal replacement therapy that allows the patient to undergo hemodialysis sessions at home. Due to the growing interest in home hemodialysis, we decided to present the potential of this renal replacement method, show both its benefits and complications resulting from its use. Undoubtedly, HHD has many benefits resulting mainly from the possibility of regulating the duration of the sessions and increasing their frequency. However, this method is also burdened with numerous complications. There are training courses in the use of HHD for patients who have just been diagnosed with end-stage renal disease as well as for patients undergoing dialysis using other methods. Appropriate patient selection is an important factor for the success of home therapy. There is a fierce battle in the home hemodialysis machine market. Manufacturers are outdoing each other in innovative technologies to ensure ease of use, trouble-free operation and minimize complications. The costs of home hemodialysis include more components than the dialysis treatment itself. Home hemodialysis gives patients comfort and independence above all. This is part of nephrology that undoubtedly requires a lot of work and development, but is certainly an invention of the 21st century.

  • Open Access

    The problem of pregnancy complicated by chronic kidney disease

    by Rafał Oleszczuk, Iga Kozińska, Anna Oleszczuk, Agnieszka M. Grzebalska

    Chronic kidney disease (CKD) in high-risk pregnancies is a challenge for multidisciplinary teams of doctors. Due to the fact that the disease affects both the mother and the fetus, and the course of the pregnancy. The following article reviews the literature about the interaction between pregnancy and CKD and dialysis therapy. Even pregnancy itself can lead to a worsening of kidney dysfunction. The risk of this consequence increases with the degree of renal failure, therefore renal parameters and other pregnancy test results should be monitored. On the other hand, the most common complications of chronic kidney disease in pregnancy described in the literature include pre-eclampsia, preterm labor, intrauterine growth restriction (IUGR) or low birth weight, surgical delivery by caesarean section and miscarriage. Dialysis therapy also leads to abnormalities in the course of pregnancy, and patients require constant monitoring during its course. Attention is also drawn to the high percentage of newborns requiring intensive postpartum care. Due to the risk for the fetus and mother mentioned in the article, nephrologists and gynecologists should cooperate closely from the pre-contraceptive period in order to reduce the risk of sequelae and better control of the underlying disease.

  • Open Access

    Aristolochic acid nephropathy - still real danger

    by Rafał Oleszczuk, Agnieszka M. Grzebalska, Iga Kozińska, Maciej Orczykowski, Anna Oleszczuk

    Arystolocholic acid nephropathy is chronic kidney disease caused by the use of substances of natural origin that contain arystolocholic acid. The effects of their use are arystolochic acid nephropathies, which include "Chinese Herbs" nephropathy. The course of the disease is very fast, resulting in progression to end-stage renal disease, and in the future it results in the development of urinary tract cancer. That is why it is so important to recognize it early and start treatment. However, due to disease progression, some patients require dialysis and even kidney transplantation. Although the World Health Organization is trying to stop the spread of the use of harmful substances, there are still reports of this nephropathy appearing in some populations. Despite warnings from the Food and Drug Administration regarding the safety of botanicals containing arystolochic acid and its classification as a human carcinogen, products containing it are still available for purchase online. The purpose of the literature review below is to analyze the latest knowledge on aristolochic acid nephropathy and its associated complication.


  • Open Access

    The use of artificial intelligence in nephrology

    by Weronika Buczek, Mikołaj Wiśniewski, Rafał Oleszczuk, Iga Kozińska, Maciej Orczykowski

    Introduction and methods Artificial Intelligence(AI) is a relatively new branch of science that studies the display of intelligent behavior by machines and its use in advanced analysis and computation. Due to the potential use of AI, it has also been introduced into medicine and nephrology. The following article is an analysis of the current knowledge on the potential of AI in nephrology and its relevance to clinicians based on the latest publications contained in the PubMed and Google Scholar databases. Stage of knowledge AI found its application in the prognosis of the development of IgA nephropathy thanks to the use of a neural network, which by analyzing the results of research and the drugs used in a large group of patients has learned to detect patients at high risk of developing severe complications at the beginning of the disease. What is more, AI makes it possible to detect DKD earlier and delay renal replacement therapy. In patients undergoing hemodialysis, artificial intelligence developed a model that calculated the appropriate duration of the procedure and adjusted drugs to control blood pressure. Another example of the use of AI is its use in relation to patients undergoing kidney transplantation. The AI calculates the beneficial concentration of an immunosuppressive drug specifically for a given patient, which allows clinicians to limit adverse effects. Summary AI is a breakthrough technology that is constantly being developed. Despite the high cost of implementing this technology, it is believed that it could represent the future of medicine and be a new way in treatment techniques and in the early detection of diseases in nephrology.


  • Open Access

    The use of the KTP 532 nm vascular laser in the treatment of erythema and telangiectasia caused by low temperature exposure - case report

    by Urszula Kozińska, Jordi Gras-Ozimek, Aleksander Gras-Ozimek, Sylwia Skwira, Rafał Oleszczuk

    The use of the KTP 532 nm vascular laser in the treatment of erythema and telangiectasia caused by low temperature exposure - case report. A case report. The paper presents a case of effective treatment of frostbite vascular lesions in the face with the use of a 532nm KTP laser in a 55-year-old man with a long history of skin exposure to low temperatures. Aim. The aim of this study is to draw attention to the possibility of using laser therapy in the treatment of skin disorders that are a complication of exposure to low temperatures. In the article below, we present the reduction of vascular lesions of the facial skin during a series of laser treatments with the use of the 532nm laser, meeting the growing interest of patients and doctors in the use of laser therapy in the treatment of skin vascular lesions. Conclusions. The use of laser therapy with the KTP 532nm laser can be an important and effective element in the treatment of skin vascular lesions.


  • Open Access

    COVID-19 impact on kidneys

    by Maciej Orczykowski, Rafał Oleszczuk, Agnieszka Grzebalska

    Introduction and purposeThe COVID-19 pandemic, which has been ongoing since early 2020, has significantly affected the health care system worldwide. SARS-CoV-2 virus being the etiological factor of the disease has a high affinity for the renal organ. The purpose of this study was to provide an overview of the current knowledge of the problem of frequent AKI in the course of coronavirus infection, the impact of COVID-19 disease in patients with chronic kidney disease and on renal replacement therapy or dialysis.Review methodIn the process of writing, we used available articles and scientific papers in Pubmed and Google Scholar databases based on keywords: COVID-19, SARS-CoV-2, AcuteKidneyInjury, ChronicKidneyDisease.State of knowledgeSARS-CoV-2 virus enters target cells through the ACE2 receptor. In the pathophysiology of AKI in the course of COVID-19, a key role is attributed to secondary damage mechanisms such as cytokine storm, hypoperfusion with hypoxia, endothelial dysfunction. The incidence of acute kidney injury ranges from 5.1% to 36.6%. The development of AKI, renal transplant status, the presence of chronic kidney disease or renal replacement therapy is associated with an increased risk of severe course and higher mortality on COVID-19. SummaryThe COVID-19 pandemic has posed new logistical and therapeutic challenges to the health care system. Due to the high tropism of SARS-CoV-2 to the kidneys and the frequent occurrence of AKI during the course of the infection, nephrology patients, those on renal replacement therapy and those awaiting transplantation should be placed under special surveillance. Patients in these groups are at particular risk for a severe course of COVID-19.